In LCC, SETD2 mutations were clearly linked to shorter OS (p = 0.026, Figure 4A), a finding supported by a trend toward worse OS in the external cohort (p = 0.056, Figure 4B). Here, SETD2 is linked to leukoencephalopathy with calcifications and cysts.